Stay updated on Carfilzomib, Iberdomide, Dexamethasone Clinical Trial
Sign up to get notified when there's something new on the Carfilzomib, Iberdomide, Dexamethasone Clinical Trial page.

Latest updates to the Carfilzomib, Iberdomide, Dexamethasone Clinical Trial page
- Check4 days agoChange DetectedRevision: v3.4.3 was added to the page. No substantive study details or eligibility criteria appear to have changed.SummaryDifference21%

- Check11 days agoChange DetectedThe page now lists 'Multiple myeloma' as a disease/topic and adds MedlinePlus Genetics as a related topic, which enhances context and navigation without altering the study details.SummaryDifference0.1%

- Check18 days agoChange DetectedA Lancet Oncology article on carfilzomib dosing (A.R.R.O.W.) was added to the Publications section with new update dates and was subsequently removed.SummaryDifference0.3%

- Check25 days agoChange DetectedThe page now displays Revision: v3.4.2, replacing Revision: v3.4.1, with no observed changes to core study details or data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check32 days agoChange DetectedRevision tag updated to v3.4.1, replacing the previous v3.4.0.SummaryDifference0.0%

- Check40 days agoChange DetectedAdded related topics: Multiple myeloma and MedlinePlus Genetics to the study page.SummaryDifference0.1%

Stay in the know with updates to Carfilzomib, Iberdomide, Dexamethasone Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Carfilzomib, Iberdomide, Dexamethasone Clinical Trial page.